Hi-Tech Pharmacal Co. (HITK) Misses Q4 EPS by 8c; Revs Light
Get Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Weighted average common shares outstanding-basic: 13.86M
Today's EPS Names:
SYBX, DSGN, ATRA, More
Financial Fact:
Weighted average common shares outstanding-basic: 13.86M
Today's EPS Names:
SYBX, DSGN, ATRA, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.79, $0.08 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $55.63 million versus the consensus estimate of $55.73 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- Comtech Telecom (CMTL) Misses Q2 EPS by 5c
- HSBC Upgrades Raia Drogasil SA (RADL3:BZ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!